Philip Morris International Inc. (PM)
Philip Morris: King Of Tobacco In Consolidation Stage - Wait For A Dip
PM's leadership in smoke-free products, profitable growth trends, and secure dividend prospects justify a Buy on pullbacks, especially for swing traders within the $150s–$180s range. Smoke-free revenues now comprise 43% of sales, with IQOS/ZYN/VEEV delivering double-digit volume growth in select regions, supporting the management's adj EPS growth target at 3Y CAGR of +10%. These may very well temper the risks from the declining cigarette volumes amid price sensitivity, attributed to the likely to remain higher inflationary pressure in the intermediate term.
Philip Morris: IQOS And ZYN Offset Combustibles Volume Decline
Philip Morris International delivered strong FQ1 2026 results, with EPS of $1.96 and 9% YoY revenue growth, mostly driven by smoke-free products. But growth potential from smoke-free offerings, notably IQOS and ZYN, is tempered by declining combustible product sales. Despite the mixed dynamics, PM trades at a significant P/E premium to the sector and historical averages.
Philip Morris to Post $500 Million Impairment on Canada Affiliate
Philip Morris International said it is booking a roughly $500 million impairment charge in the second quarter to reduce the carrying value of its investment in Canadian affiliate Rothmans Benson & Hedges, or RBH.
Philip Morris: The Pullback Is A Gift For Long-Term Investors
Philip Morris: The Pullback Is A Gift For Long-Term Investors
Coca-Cola or Philip Morris: Which Is the Better Short Bet Right Now?
Coca-Cola (NYSE: KO | KO Price Prediction) and Philip Morris International (NYSE: PM) both posted Q1 2026 beats within a week of each other.
Philip Morris: Room To Run Toward Fair Value
Philip Morris International is reiterated as a 'Buy,' offering high income, robust dividend growth, and capital appreciation at a modest discount to fair value. PM's smoke-free segment now comprises 43% of revenue, with IQOS surpassing Marlboro as the leading nicotine brand in key markets. PM targets a 2x net debt/EBITDA by end-2026, likely prompting a credit upgrade and enabling share buybacks to further boost EPS.
Philip Morris: No Reason To Get Involved Today
Philip Morris (PM) exhibits strong growth in smokeless tobacco but trades near fair value after a 6% post-earnings rally. SFPs now comprise 41.4% of PM's product mix, driving high-single-digit shipment growth and international momentum. Despite a solid 3.5% yield and robust SFP performance, the risk/reward is balanced with limited upside at current valuation.
Philip Morris International Inc (PM) Q1 2026 Earnings Call Highlights: Strong Smoke-Free Growth and EPS Surge
Net Revenues: Over $10 billion, a 9% increase in reported terms and 2.7% organically.Adjusted Operating Income: Grew by 10% to $4.2 billion with close to 1% or
Philip Morris: Growth At An Expensive Price (Rating Upgrade)
Philip Morris International delivered strong Q1'26 results on Wednesday, with alternative products now comprising 43% of total revenues. I see PM as a reliable income vehicle, with the tobacco and alternative products company on track to pay out ~73% of adjusted EPS this year. PM confirmed its adjusted EPS guidance (excluding currency impact) for FY 2026, reflecting momentum in non-traditional tobacco products and robust emerging markets exposure.
Philip Morris stock jumps 7% as smoke-free growth drives beat
Shares of Philip Morris International rose about 7% on Wednesday after the tobacco giant reported stronger-than-expected first-quarter results, driven by robust growth in its smoke-free business and solid international performance. The company's earnings and revenue both exceeded analyst expectations, with adjusted earnings per share of $1.96 topping consensus estimates of around $1.83.
Philip Morris Sales Rise on Smoke-Free Business Growth
Philip Morris International logged higher revenue in the first quarter, with particularly strong growth in its smoke-free business.
Philip Morris cuts annual profit forecast
Philip Morris International cut its annual profit forecast on Wednesday, signaling pressure from heightened competition in tobacco products and regulatory uncertainty over its Zyn nicotine pouches.
